Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
STEM > SEC Filings for STEM > Form 8-K on 10-Jun-2013All Recent SEC Filings

Show all filings for STEMCELLS INC | Request a Trial to NEW EDGAR Online Pro

Form 8-K for STEMCELLS INC


10-Jun-2013

Change in Directors or Principal Officers, Financial Statements and Exhibits


Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Earlier today, StemCells, Inc. (the "Company") issued a press release announcing the hire of three new employees into product development roles at the Company and the creation of a new corporate function responsible for establishing scientific and strategic alliances and for building on the Company's existing stem cell technology platform. A copy of the press release is attached hereto as Exhibit 99.1.

Appointment of New Executive Vice President and Head of Research and Development

On June 10, 2013, the Company announced the appointment of Eliseo Oreste Salinas, MD, MSc, to the position of Executive Vice President and Head of Research and Development, effective immediately. Dr. Salinas brings more than 22 years of research, clinical translation, and product development experience. Prior to joining the Company, Dr. Salinas served as Executive Vice President, Head of Development and Chief Medical Officer of Elan Pharmaceuticals. Before joining Elan, Dr. Salinas held senior management positions at Shire plc, Adolor Corporation and Wyeth-Ayerst Research. In his new role at the Company as EVP and Head of Research and Development, Dr. Salinas will be responsible for the Company's research, product development and clinical translation activities. He will serve on the Company's Executive Officer Committee and report directly to the Company's Chief Executive Officer.

Appointment of New Executive Vice President, Scientific and Strategic Alliances

Pursuant to Company action taken on June 6, 2013, the Company has appointed Ann Tsukamoto, PhD, to the position of Executive Vice President, Scientific and Strategic Alliances. Previously, Dr. Tsukamoto served as the Company's Executive Vice Present of Research and Development, a position she held since September 2008. In her new role, Dr. Tsukamoto will be responsible for developing the Company's alliances with research institutions, corporations, government agencies, and disease foundations. She will continue to serve on the Company's Executive Officer Committee and report directly to the Company's Chief Executive Officer.



Item 9.01 Financial Statements and Exhibits.

(c) Exhibits.

Exhibit 99.1 Press Release, dated June 10, 2013, announcing new hires and creation of new executive function at the Company.


Top of the Form

  Add STEM to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for STEM - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.